Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Technology evaluation: DCVax, Northwest biotherapeutics
Keith L. Knutson
Jacksonville, FL
Research output
:
Contribution to journal
›
Review article
›
peer-review
13
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Technology evaluation: DCVax, Northwest biotherapeutics'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Phase II Clinical Trials
97%
Clinical Trials, Phase I
96%
Technology
78%
Phase III Clinical Trials
47%
Kidney Neoplasms
44%
Neoplasm Antigens
42%
Glioblastoma
39%
Neoplasms
38%
Dendritic Cells
35%
Non-Small Cell Lung Carcinoma
35%
Immunotherapy
35%
Prostate
33%
Vaccination
31%
Prostatic Neoplasms
31%
Hormones
28%
Lung
21%
Brain
19%
Therapeutics
6%
Chemical Compounds
Time
42%